175 related articles for article (PubMed ID: 3351855)
1. Potential antitumor agents. 55. 6-Phenylphenanthridine-4-carboxamides: a new class of DNA-intercalating antitumor agents.
Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1988 Apr; 31(4):774-9. PubMed ID: 3351855
[TBL] [Abstract][Full Text] [Related]
2. Potential antitumor agents. 57. 2-Phenylquinoline-8-carboxamides as "minimal" DNA-intercalating antitumor agents with in vivo solid tumor activity.
Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1989 Feb; 32(2):396-401. PubMed ID: 2913299
[TBL] [Abstract][Full Text] [Related]
3. Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of "minimal" DNA-intercalating agents which may not act via topoisomerase II.
Denny WA; Rewcastle GW; Baguley BC
J Med Chem; 1990 Feb; 33(2):814-9. PubMed ID: 2153829
[TBL] [Abstract][Full Text] [Related]
4. Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
J Med Chem; 1987 Apr; 30(4):664-9. PubMed ID: 3560161
[TBL] [Abstract][Full Text] [Related]
5. Potential antitumor agents. 64. Synthesis and antitumor evaluation of dibenzo[1,4]dioxin-1-carboxamides: a new class of weakly binding DNA-intercalating agents.
Lee HH; Palmer BD; Boyd M; Baguley BC; Denny WA
J Med Chem; 1992 Jan; 35(2):258-66. PubMed ID: 1310119
[TBL] [Abstract][Full Text] [Related]
6. Potential antitumor agents. 56. "Minimal" DNA-intercalating ligands as antitumor drugs: phenylquinoline-8-carboxamides.
Atwell GJ; Bos CD; Baguley BC; Denny WA
J Med Chem; 1988 May; 31(5):1048-52. PubMed ID: 3361574
[TBL] [Abstract][Full Text] [Related]
7. Potential antitumor agents. 54. Chromophore requirements for in vivo antitumor activity among the general class of linear tricyclic carboxamides.
Palmer BD; Rewcastle GW; Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1988 Apr; 31(4):707-12. PubMed ID: 3351846
[TBL] [Abstract][Full Text] [Related]
8. Dimeric analogues of non-cationic tricyclic aromatic carboxamides are a new class of cytotoxic agents.
Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
Anticancer Drug Des; 1999 Jun; 14(3):281-9. PubMed ID: 10500503
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic and DNA binding properties of aminoalkyl derivatives of di- and triazaphenanthrenes.
Argiropoulos G; Bates MR; Cherubim P; Deady LW; Ganakas AM; Baguley BC; Denny WA
Anticancer Drug Des; 1992 Aug; 7(4):285-96. PubMed ID: 1510798
[TBL] [Abstract][Full Text] [Related]
10. Electron-deficient DNA-intercalating agents as antitumor drugs: aza analogues of the experimental clinical agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Chen Q; Deady LW; Baguley BC; Denny WA
J Med Chem; 1994 Mar; 37(5):593-7. PubMed ID: 8126699
[TBL] [Abstract][Full Text] [Related]
11. Potential antitumor agents. 51. Synthesis and antitumor activity of substituted phenazine-1-carboxamides.
Rewcastle GW; Denny WA; Baguley BC
J Med Chem; 1987 May; 30(5):843-51. PubMed ID: 3572972
[TBL] [Abstract][Full Text] [Related]
12. Potential antitumor agents. 49. 5-substituted derivatives of N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide with in vivo solid-tumor activity.
Denny WA; Atwell GJ; Rewcastle GW; Baguley BC
J Med Chem; 1987 Apr; 30(4):658-63. PubMed ID: 3560160
[TBL] [Abstract][Full Text] [Related]
13. Highly stable phenanthridinium frameworks as a new class of tunable DNA binding agents with cytotoxic properties.
Parenty AD; Smith LV; Guthrie KM; Long DL; Plumb J; Brown R; Cronin L
J Med Chem; 2005 Jul; 48(14):4504-6. PubMed ID: 15999988
[TBL] [Abstract][Full Text] [Related]
14. Novel antitumor agent family of 1H-benzo[c,d]indol-2-one with flexible basic side chains: synthesis and biological evaluation.
Yin H; Xu Y; Qian X
Bioorg Med Chem; 2007 Feb; 15(3):1356-62. PubMed ID: 17129733
[TBL] [Abstract][Full Text] [Related]
15. DNA-binding properties and antitumour activity of monofunctional alkylating groups attached to the DNA-intercalating chromophore phenanthridine: n-bromoalkylphenanthridinium bromides.
Wickham G; Prakash AS; Wakelin LP; McFadyen WD
Biochim Biophys Acta; 1991 Apr; 1073(3):528-37. PubMed ID: 2015276
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives.
Perni RB; Wentland MP; Huang JI; Powles RG; Aldous S; Klingbeil KM; Peverly AD; Robinson RG; Corbett TH; Jones JL; Mattes KC; Rake JB; Coughlin SA
J Med Chem; 1998 Sep; 41(19):3645-54. PubMed ID: 9733489
[TBL] [Abstract][Full Text] [Related]
17. Potential antitumor agents. 53. Synthesis, DNA binding properties, and biological activity of perimidines designed as "minimal" DNA-intercalating agents.
Herbert JM; Woodgate PD; Denny WA
J Med Chem; 1987 Nov; 30(11):2081-6. PubMed ID: 3669016
[TBL] [Abstract][Full Text] [Related]
18. A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine). Synthesis, DNA binding, and biological properties.
Larue L; Rivalle C; Muzard G; Paoletti C; Bisagni E; Paoletti J
J Med Chem; 1988 Oct; 31(10):1951-6. PubMed ID: 3172128
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents.
Kock I; Heber D; Weide M; Wolschendorf U; Clement B
J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antitumor evaluation and DNA photocleaving activity of novel methylthiazonaphthalimides with aminoalkyl side chains.
Li Z; Yang Q; Qian X
Bioorg Med Chem Lett; 2005 Jun; 15(12):3143-6. PubMed ID: 15876532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
